论文部分内容阅读
目的本文旨在评价2D与3D高清胸腔镜下对肺癌手术的临床应用价值。方法选取2016年8月-2017年3月90例行2D和50例行3D胸腔镜下肺叶切除及淋巴结清扫的手术患者,比较2组患者围手术期相关指标。结果 2组均无中转开胸及围术期死亡病例。3D-VATS组与2D-VATS组比较,肺癌完全切除术手术时间明显缩短(分别为110.12vs122.66min,P<0.05),术中出血量亦明显减少(分别为98.8vs123m L,P<0.05),且差异具有统计学意义。2组间性别、年龄、肿瘤部位、术后外科分期(p-TNM)、肺功能、清扫淋巴结数、总胸引量、术后胸管时间、术后住院日、术后并发症差异无统计学意义(P>0.05)。结论 3D高清胸腔镜是技术的又一进步,有助于促进肿瘤内镜治疗领域的提高。相比较于2D系统,3D胸腔镜在肺癌手术治疗中是安全可行的,术中失血量减少,手术时间更短。
Objective This article aims to evaluate the clinical value of 2D and 3D HD thoracoscopic surgery for lung cancer. Methods From August 2016 to March 2017, 90 patients underwent 2D lobectomy and 50 underwent thoracoscopic lobectomy and lymphadenectomy. The perioperative indexes were compared between the two groups. Results There were no cases of thoracotomy and perioperative death in both groups. Compared with 2D-VATS group, the operation time of complete resection of lung cancer was significantly shorter in 3D-VATS group (110.12 vs 122.66min, P <0.05, respectively) and the amount of bleeding during operation was significantly decreased (98.8 vs. 123m L, P <0.05, , And the difference was statistically significant. No statistical differences in gender, age, tumor location, postoperative surgical stage (p-TNM), pulmonary function, number of lymph nodes dissected, total thoracic index, postoperative chest tube time, postoperative hospital stay and postoperative complications Significance (P> 0.05). Conclusion 3D HD thoracoscopy is another technical progress, which will help promote the improvement of endoscopic treatment. Compared with 2D system, 3D thoracoscope in the surgical treatment of lung cancer is safe and feasible, less blood loss during surgery, shorter operation time.